| Net Cash Provided by (Used in) Operating Activities |
$1,820,000 |
USD |
-38% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$24,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$184,000 |
USD |
-103% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,980,000 |
USD |
-134% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$13,717,000 |
USD |
-28% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$57,995,000 |
USD |
-8.3% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$63,995,000 |
USD |
1.2% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$34,000 |
USD |
-33% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$6,421,000 |
USD |
9.7% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$41,440,000 |
USD |
1.5% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$82,000 |
USD |
64% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$6,000,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$702,000 |
USD |
2.8% |
Q3 2025 |
Q3 2025 |